Stay updated with breaking news from 45337c10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cambiar Investors LLC decreased its holdings in shares of Incyte Co. (NASDAQ:INCY – Get Rating) by 0.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 122,440 shares of the biopharmaceutical company’s stock after selling 986 shares during the period. […]
Signaturefd LLC boosted its position in shares of Incyte Co. (NASDAQ:INCY – Get Rating) by 25.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,781 shares of the biopharmaceutical company’s stock after buying an additional 361 shares during the […]
Signaturefd LLC raised its position in Incyte Co. (NASDAQ:INCY – Get Rating) by 25.4% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 1,781 shares of the biopharmaceutical company’s stock after purchasing an additional 361 shares during the period. Signaturefd LLC’s holdings in Incyte were worth $143,000 as of its most recent SEC filing. […]
StockNews.com cut shares of Incyte (NASDAQ:INCY – Get Rating) from a strong-buy rating to a buy rating in a research note issued to investors on Wednesday. INCY has been the subject of several other reports. Piper Sandler restated an overweight rating and set a $100.00 price target on shares of Incyte in a report on […]
Incyte (NASDAQ:INCY – Get Rating) had its price objective lifted by Morgan Stanley from $76.00 to $77.00 in a report released on Wednesday morning, The Fly reports. They currently have an equal weight rating on the biopharmaceutical company’s stock. A number of other brokerages have also recently commented on INCY. Piper Sandler reaffirmed an overweight […]